Evidence map›Paper›PMID 33501963›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.

Jean B Nachega, Ashraf Grimwood, Hassan Mahomed, Geoffrey Fatti, Wolfgang Preiser, Oscar Kallay, Placide K Mbala, Jean-Jacques T Muyembe, Edson Rwagasore, Sabin Nsanzimana and 9 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jean B NachegaDepartment of Medicine and Centre for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa.
Ashraf GrimwoodKheth'Impilo AIDS Free Living, Cape Town, South Africa.
Hassan MahomedDivision of Health Systems and Public Health, Department of Global Health, Stellenbosch Faculty of Medicine and Health Sciences and Western Cape Department of Health, Cape Town, South Africa.
Geoffrey FattiKheth'Impilo AIDS Free Living, Cape Town, South Africa.
Wolfgang PreiserDivision of Medical Virology, Department of Pathology, Stellenbosch University Faculty of Medicine and Health Sciences, and National Health Laboratory Service, Cape Town, South Africa.
Oscar KallayDepartment of Ophthalmology, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium.
Placide K MbalaNational Institute of Biomedical Research and Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jean-Jacques T MuyembeNational Institute of Biomedical Research and Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Edson RwagasoreRwanda Biomedical Center, Kigali, Rwanda.
Sabin NsanzimanaRwanda Biomedical Center, Kigali, Rwanda.
Daniel NgamijeRwanda Ministry of Health, Kigali, Rwanda.
Jeanine CondoUniversity of Rwanda, School of Public Health, Kigali, Rwanda.
Mohsin SidatFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Emilia V NoormahomedFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Michael ReidDepartment of Medicine, HIV, Infectious Diseases & Global Medicine Division, University of California, San Francisco, California, USA.
Beatrice LukeniResilient and Responsive Health Systems Project, ICAP at Columbia University, Lubumbashi, Democratic Republic of the Congo.
Fatima SulemanDiscipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Alfred MtetaKilimanjaro Christian Medical University College, Moshi, United Republic of Tanzania.
Alimuddin ZumlaDepartment of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom.

Funding

Stellenbosch University Clinical Trial Unit, Cape Town, South AfricaU01AI069521 · NIAID · STELLENBOSCH UNIVERSITY · PI COTTON, MARK FREDRIC · 2007 to 2011
$8.4M
African Association for Health Professions Education and ResearchR25TW011217 · FIC · INFECTIOUS DISEASES INSTITUTE · PI ADEJUMO, PRISCA, NACHEGA, JEAN BISIMWA · 2018 to 2023
$3.9M
The University Eduardo Mondlane/UCSD Health-Professional Education Partnership InitiativeR25TW011216 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2018 to 2022
$3.2M
Enhanced Advanced Biomedical Research Training for MozambiqueD43TW010135 · FIC · EDUARDO MONDLANE UNIVERSITY · PI NOORMAHOMED, EMILIA VIRGINIA · 2015 to 2019
$3.2M
University of Pittsburgh HIV-Comorbidities Research Training Program in South AfricaD43TW010937 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NACHEGA, JEAN BISIMWA, SEEDAT, SORAYA · 2019 to 2023
$1.2M
FIC NIH HHS D43 TW010135FIC NIH HHS D43 TW010937FIC NIH HHS R25 TW011216FIC NIH HHS R25 TW011217NIAID NIH HHS U01 AI069521
6 · The paper itself

Abstract

The arrival of coronavirus disease 2019 (COVID-19) on the African continent resulted in a range of lockdown measures that curtailed the spread of the infection but caused economic hardship. African countries now face difficult choices regarding easing of lockdowns and sustaining effective public health control measures and surveillance. Pandemic control will require efficient community screening, testing, and contact tracing; behavioral change interventions; adequate resources; and well-supported, community-based teams of trained, protected personnel. We discuss COVID-19 control approaches in selected African countries and the need for shared, affordable, innovative methods to overcome challenges and minimize mortality. This crisis presents a unique opportunity to align COVID-19 services with those already in place for human immunodeficiency virus, tuberculosis, malaria, and non communicable diseases through mobilization of Africa's interprofessional healthcare workforce. By addressing the challenges, the detrimental effect of the COVID-19 pandemic on African citizens can be minimized.

Indexed as

COVID-19PandemicsAfricaCommunicable Disease ControlContact TracingHumansMorbiditySARS-CoV-2Africacontact traceCOVID-19SARS-CoV-2screening testing

Identifiers

PMID33501963
PMCPMC7314180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.